Tumorprotein63 / p63 / Chronic ulcerative stomatitis protein / CUSP / Keratinocyte transcription factor KET / ...p63 / Chronic ulcerative stomatitis protein / CUSP / Keratinocyte transcription factor KET / Transformation-related protein 63 / TP63 / Tumor protein p73-like / p73L / p40 / p51
Mass: 7323.190 Da / Num. of mol.: 2 Fragment: Tetramerization domain of 63, UNP residues 397-455 Mutation: K21E Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: KET, P63, P73H, P73L, TP63, TP73L / Production host: Escherichia coli (E. coli) / Strain (production host): BL21 / References: UniProt: Q9H3D4
#2: Protein/peptide
Tumorproteinp73 / p53-like transcription factor / p53-related protein
Mass: 6034.894 Da / Num. of mol.: 2 Fragment: Tetramerization domain of p73, UNP residues 351-398 Mutation: E15K Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: P73, TP73 / Production host: Escherichia coli (E. coli) / Strain (production host): BL21 / References: UniProt: O15350
-
Experimental details
-
Experiment
Experiment
Method: SOLUTION NMR
NMR experiment
Conditions-ID
Experiment-ID
Solution-ID
Type
1
1
1
3D HN(CA)CB
1
2
1
3DHN(CA)CO
1
3
1
3D 1H-15N NOESY
1
4
2
3D HN(CA)CB
1
5
2
3DHN(CA)CO
1
6
2
3D 1H-15N NOESY
1
7
1
3DH(CCO)NH
1
8
1
3DC(CO)NH
1
9
2
3DH(CCO)NH
1
10
2
3DC(CO)NH
1
11
1
2D 1H-13C HSQC aromatic
1
12
2
2D 1H-13C HSQC aromatic
1
13
1
2D (H)CB(CG)CCH-TOCSY
1
14
2
2D (H)CB(CG)CCH-TOCSY
1
15
1
2D (HB)CB(CDCD)HD
1
16
2
2D (HB)CB(CDCD)HD
1
17
1
3D 1H-13C NOESY aromatic
1
18
2
3D 1H-13C NOESY aromatic
1
19
1
3D 13C/15N-filtered NOESY-[13C,1H]-HSQC
1
20
2
3D 13C/15N-filtered NOESY-[13C,1H]-HSQC
1
21
1
3D 13C/15N-filtered NOESY-[15N,1H]-TROSY
1
22
2
3D 13C/15N-filtered NOESY-[15N,1H]-TROSY
1
23
1
3D 1H-13C NOESY
1
24
2
3D 1H-13C NOESY
1
25
1
2D 1H-13C HSQC
1
26
2
2D 1H-13C HSQC
1
27
1
2D 1H-15N HSQC
1
28
2
2D 1H-15N HSQC
1
29
5
2D 1H-15N HSQC
1
30
6
2D 1H-15N HSQC
1
31
3
3D lr-HNCO
1
32
4
3D lr-HNCO
2
33
7
3D lr-HNCO
-
Sample preparation
Details
Solution-ID
Contents
Solvent system
1
0.5 mM [U-100% 13C; U-100% 15N] p63 tetramerization domain, 0.5 mM p73 tetramerization domain, 25 mM HEPES, 50 mM sodium chloride, 95% H2O/5% D2O
95% H2O/5% D2O
2
0.5 mM p63 tetramerization domain, 0.5 mM [U-100% 13C; U-100% 15N] p73 tetramerization domain, 25 mM HEPES, 50 mM sodium chloride, 95% H2O/5% D2O
95% H2O/5% D2O
3
0.5 mM [U-100% 15N] p63 tetramerization domain, 0.5 mM [U-100% 13C] p63 tetramerization domain, 1 mM p73 tetramerization domain, 25 mM HEPES, 50 mM sodium chloride, 95% H2O/5% D2O
95% H2O/5% D2O
4
1 mM p63 tetramerization domain, 0.5 mM [U-100% 15N] p73 tetramerization domain, 0.5 mM [U-100% 13C] p73 tetramerization domain, 25 mM HEPES, 50 mM sodium chloride, 95% H2O/5% D2O
95% H2O/5% D2O
5
0.5 mM [U-100% 15N] p63 tetramerization domain, 0.5 mM p73 tetramerization domain, 25 mM HEPES, 50 mM sodium chloride, 100% D2O
100% D2O
6
0.5 mM p63 tetramerization domain, 0.5 mM [U-100% 15N] p73 tetramerization domain, 25 mM HEPES, 50 mM sodium chloride, 100% D2O
100% D2O
7
0.5 mM [U-100% 15N] p63 tetramerization domain, 0.5 mM [U-100% 13C] p63 tetramerization domain, 0.5 mM [U-100% 15N] p73 tetramerization domain, 0.5 mM [U-100% 13C] p73 tetramerization domain, 25 mM HEPES, 50 mM sodium chloride, 95% H2O/5% D2O
95% H2O/5% D2O
Sample
Conc. (mg/ml)
Component
Isotopic labeling
Solution-ID
0.5mM
p63 tetramerization domain-1
[U-100% 13C; U-100% 15N]
1
0.5mM
p73 tetramerization domain-2
1
25mM
HEPES-3
1
50mM
sodium chloride-4
1
0.5mM
p63 tetramerization domain-5
2
0.5mM
p73 tetramerization domain-6
[U-100% 13C; U-100% 15N]
2
25mM
HEPES-7
2
50mM
sodium chloride-8
2
0.5mM
p63 tetramerization domain-9
[U-100% 15N]
3
0.5mM
p63 tetramerization domain-10
[U-100% 13C]
3
1mM
p73 tetramerization domain-11
3
25mM
HEPES-12
3
50mM
sodium chloride-13
3
1mM
p63 tetramerization domain-14
4
0.5mM
p73 tetramerization domain-15
[U-100% 15N]
4
0.5mM
p73 tetramerization domain-16
[U-100% 13C]
4
25mM
HEPES-17
4
50mM
sodium chloride-18
4
0.5mM
p63 tetramerization domain-19
[U-100% 15N]
5
0.5mM
p73 tetramerization domain-20
5
25mM
HEPES-21
5
50mM
sodium chloride-22
5
0.5mM
p63 tetramerization domain-23
6
0.5mM
p73 tetramerization domain-24
[U-100% 15N]
6
25mM
HEPES-25
6
50mM
sodium chloride-26
6
0.5mM
p63 tetramerization domain-27
[U-100% 15N]
7
0.5mM
p63 tetramerization domain-28
[U-100% 13C]
7
0.5mM
p73 tetramerization domain-29
[U-100% 15N]
7
0.5mM
p73 tetramerization domain-30
[U-100% 13C]
7
25mM
HEPES-31
7
50mM
sodium chloride-32
7
Sample conditions
Conditions-ID
Ionic strength
pH
Pressure (kPa)
Temperature (K)
1
75
7
ambientatm
310K
2
5
6
ambientatm
310K
-
NMR measurement
NMR spectrometer
Type
Manufacturer
Model
Field strength (MHz)
Spectrometer-ID
Bruker Avance II
Bruker
AVANCEII
500
1
Bruker Avance
Bruker
AVANCE
700
2
Bruker Avance
Bruker
AVANCE
800
3
Bruker Avance
Bruker
AVANCE
900
4
-
Processing
NMR software
Name
Version
Developer
Classification
CYANA
3.97
Guntert, MumenthalerandWuthrich
structuresolution
TALOS+
Cornilescu, DelaglioandBax
dataanalysis
OPALp
1.4
Luginbuhl, Guntert, BilleterandWuthrich
refinement
Sparky
3.114
Goddard
peakpicking
Sparky
3.114
Goddard
chemicalshiftassignment
TopSpin
3.2
BrukerBiospin
processing
TopSpin
3.2
BrukerBiospin
dataanalysis
Refinement
Method: molecular dynamics / Software ordinal: 1
NMR constraints
NOE constraints total: 2582 / NOE intraresidue total count: 412 / NOE long range total count: 850 / NOE medium range total count: 614 / NOE sequential total count: 706 / Hydrogen bond constraints total count: 440 / Protein chi angle constraints total count: 0 / Protein other angle constraints total count: 0 / Protein phi angle constraints total count: 180 / Protein psi angle constraints total count: 180
NMR representative
Selection criteria: closest to the average
NMR ensemble
Average torsion angle constraint violation: 4.96 ° / Conformer selection criteria: target function / Conformers calculated total number: 200 / Conformers submitted total number: 20 / Maximum torsion angle constraint violation: 6.66 ° / Maximum upper distance constraint violation: 0.17 Å
NMR ensemble rms
Distance rms dev: 0.0076 Å
+
About Yorodumi
-
News
-
Feb 9, 2022. New format data for meta-information of EMDB entries
New format data for meta-information of EMDB entries
Version 3 of the EMDB header file is now the official format.
The previous official version 1.9 will be removed from the archive.
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi